June 24 (Reuters) - Fortrea Holdings Inc FTRE.O:
FORTREA & EMERY PHARMA ANNOUNCE STRATEGIC COLLABORATION TO DELIVER FDA COMPLIANT DRUG-DRUG-INTERACTION STUDIES USING RIFAMPIN
Source text: ID:nGNX1kMJxN
Further company coverage: FTRE.O
((Reuters.Briefs@thomsonreuters.com;))